UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition.
Mar 5, 2024
0
38
An international study, published in JAMA Oncology, in which the Clinical Oncology group of the Sant Pau Research Institute participated, has revealed that MRI monitoring in women with mutations in the BRCA1 genes significantly ...
Mar 1, 2024
0
44
The colon is often thought of as one organ, but the right and left parts of the colon have different molecular features in cancers. New research in mice from investigators at the Johns Hopkins Kimmel Cancer Center demonstrates ...
Feb 27, 2024
0
32
Researchers in China have reported the first large-scale study characterizing the proteomics and phosphoproteomics of small cell lung cancer (SCLC) clinical cohorts, providing a comprehensive picture of the proteogenomics ...
Feb 27, 2024
0
23
A new University of Kentucky Markey Cancer Center study published in JCO Precision Oncology demonstrates a feasible way to expand germline genetic testing for patients with cancer.
Feb 26, 2024
0
0
A genetic test that identifies cancer mutations in solid tumors and that was developed by researchers at Washington University School of Medicine in St. Louis has been approved for reimbursement by the Centers for Medicare ...
Feb 26, 2024
0
1
SATURDAY, Feb. 24, 2024 (HeathDay News)—Colon cancer rates are on the rise among young Americans and Americans of color, so much so that the disease is now the leading cause of cancer death for men under 50 and the second ...
Feb 25, 2024
0
19
A new research paper titled "Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas: next-generation sequencing and machine learning for full tumor exome analysis" has been published in Oncotarget.
Feb 14, 2024
0
0
Researchers have identified why some advanced estrogen receptor (ER) positive breast cancers become resistant to hormone therapy, and have identified drugs currently in development that could keep disease stable for longer ...
Feb 7, 2024
0
0
Scientists at the UC San Francisco (UCSF) and Northwestern Medicine may have found a way around the limitations of engineered T cells by borrowing a few tricks from cancer itself.
Feb 7, 2024
0
148
